Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement

Article summary

Impact Biomedical Inc. announced that the SEC declared effective the Form F-4 registration statement for its proposed business combination with Zoar Limited and Zoar Labs, with a special stockholder meeting scheduled for November 13, 2026.